Skip to main content
Clinical Trials/ISRCTN02977330
ISRCTN02977330
Completed
未知

A feasibility study in a randomised controlled wait-group design to evaluate a specific group intervention to improve psycho-vegetative self-regulation in the treatment of refractory irritable bowel syndrome; concurrent diary study of interactions between symptoms, psychosocial variables, biomedical parameters, and treatment conditions

Postdoc Programme of the Medical Faculty of the University of Heidelberg (Germany)0 sites24 target enrollmentJune 18, 2014

Overview

Phase
未知
Intervention
Not specified
Conditions
Irritable Bowel Syndrome
Sponsor
Postdoc Programme of the Medical Faculty of the University of Heidelberg (Germany)
Enrollment
24
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

Registry
who.int
Start Date
June 18, 2014
End Date
December 31, 2014
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Postdoc Programme of the Medical Faculty of the University of Heidelberg (Germany)

Eligibility Criteria

Inclusion Criteria

  • 1\. Adult male and female patients aged 18 years or older at the time of enrolment
  • 2\. At least one contact to the IBS clinic at Heidelberg University for making the diagnosis
  • 3\. Documented medical diagnosis of IBS according to Rome III criteria
  • 4\. IBS symptoms refractory to previous IBS therapies (IBS medication, antidepressants, or psychotherapies)
  • 4a. Without adequate relief (AR)
  • 4b.Subjective global assessment (SGA) at best moderately relieved on a 7\-point Likert scale
  • 5\. Entry criteria:
  • 5a.Abdominal Pain Intensity: Weekly average of worst abdominal pain in past 24 hours score of \>3\.0 on a 0 to 10 point scale and/ or
  • 5b. IBS\-D (with diarrhea): Stool Consistency: At least 2 days per week with at least one stool that has a consistency of Type 6 or Type 7 on the Bristol Stool Scale (BSS) and/ or
  • 5c. IBS\-C (with constipation): Stool Frequency \<3 complete spontaneous bowel movements (CSBMs) per week

Exclusion Criteria

  • 1\. Newly started psychotherapy or antidepressant medication (psychotherapies for at least three months or antidepressants for at least one month were allowed for admission to the study if IBS was refractory to these interventions)
  • 2\. Evidence of alcohol or substance misuse
  • 3\. Severe psychiatric co\-morbidity (e.g. bipolar disorder, schizophrenia, dementia)
  • 4\. Presence of suicidal ideation (current intent/ plans/ actions)
  • 5\. Severe organic disease (operationalized by a Karnofsky index \<70%)
  • 6\. Inability to complete the questionnaires
  • 7\. Ongoing litigation due to disability pension or compensation for personal suffering
  • 8\. Patients with lactose intolerance and fructose malabsorption were not excluded if they had no adequate relief after an appropriate exclusion diet for more than 3 weeks

Outcomes

Primary Outcomes

Not specified

Similar Trials